On June 9, 2026, Jennifer Catherine Hartnett, serving as the Chief Commercial Officer for e.l.f. Beauty, Inc. (NASDAQ:ELF), completed a transaction involving the disposal of company equity. The specific volume of shares sold amounted to 4,352 units, executed at a price point of $51.53 per share. This activity resulted in a total transaction value of $224,258.
The primary driver for this divestment was administrative in nature. The sale was executed strictly to satisfy tax and other government withholding obligations associated with the vesting of Restricted Stock Units (RSUs) issued by the company. Following the completion of this transaction, Ms. Hartnett's direct holdings in e.l.f. Beauty common stock stand at 54,056 shares. This total inventory includes 24,079 Restricted Stock Units that remain subject to the issuer's vesting schedule.
The executive sale takes place within a period of notable price fluctuation for e.l.f. Beauty equity. Over the preceding twelve months, the stock has experienced a substantial decline of 53%, bringing it to its current trading level of $60.68. However, recent market activity indicates a short-term recovery, with shares rebounding 22% over the past week. Market analysis from InvestingPro suggests that the stock may currently be trading at undervalued levels relative to its fundamentals.
Recent financial disclosures from e.l.f. Beauty provide a contrasting backdrop to the stock's price action. The company reported fourth-quarter fiscal 2026 results that surpassed consensus estimates for both earnings per share and revenue. The reported EPS of $0.32 exceeded the anticipated figure of $0.29. Revenue generation reached $449.3 million, outperforming the expected $423.23 million. This performance was supported by a 35.1% year-over-year sales increase, which notably surpassed the consensus growth estimate of 27.2%.
Despite the strong operational results, several analyst firms have recently recalibrated their price targets for e.l.f. Beauty, reflecting divergent views on the company's trajectory. Piper Sandler reduced its price target to $50 from $60, citing demand concerns, while maintaining a Neutral rating. Canaccord adjusted its target downward to $90 from $100, maintaining a Buy rating despite expressing concerns regarding brand dynamics. Morgan Stanley lowered its target to $59 from $67, noting a slowdown within the base ELF cosmetics brand. Additionally, Jefferies revised its target to $70 from $85, highlighting a reset to a lower organic growth baseline for fiscal 2027.